An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Community
Meet Dr. A. Enrique Caballero: a Boston-based endocrinologist with decades of experience providing diabetes care to the Latinx community. After…
Connect1d Canada partners with the T1D Exchange
Connect1d Canada, a digital platform that allows those with type 1 diabetes (T1D) to easily learn about and participate in…
Meet the Expert: Increasing CGM Usage and Streamlining Processes
The T1D Exchange Quality Improvement Collaborative (QIC) was established in 2016 — with the support of The Leona M. and…
A Parent’s Guide for Back-to-School with T1D
Life with diabetes can bring a lot of stress, but one of the most stressful events for parents and children…
Everything you need to know about Type 1 Diabetes now in Spanish.
We invite you to explore the new CDC’s type 1 diabetes section, and please share it in English and Spanish…
New T1D Equity Framework Partnership with Medtronic Inc.
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
Screening for T1D: Using the New T1Detect Kit
Screening for type 1 diabetes is now easier than ever before. Although screening has been available for many years, now…
Chatting with Dexcom CEO About the New G7, the Sampling Program, and the Patient Voice
There are approximately 900,000 people across the globe wearing a Dexcom continuous glucose monitor (CGM) today. “Up from 600,000 at…
We Honor These Words
“Life’s most urgent and persistent question is, What are you doing for others?” – Martin Luther King Jr T1D Exchange…
